This will be an open label pilot study of Concerta in the treatment of adults with the
diagnosis of Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS). We
hypothesize ADHD symptomatology in adults with ADHD NOS will be responsive to Concerta
treatment in the short term and Concerta-associated response of ADHD symptomatology in adults
with ADHD NOS will be sustained over the medium term.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.